SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 272 filers reported holding SAGE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $229,000 | -24.9% | 4,039 | -0.8% | 0.00% | 0.0% |
| Q1 2021 | $305,000 | -5.6% | 4,071 | +9.2% | 0.00% | 0.0% |
| Q4 2020 | $323,000 | +41.7% | 3,729 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $228,000 | -32.5% | 3,729 | -20.3% | 0.00% | -50.0% |
| Q4 2019 | $338,000 | -49.9% | 4,676 | -2.7% | 0.00% | -50.0% |
| Q3 2019 | $674,000 | -30.2% | 4,807 | -8.9% | 0.00% | -20.0% |
| Q2 2019 | $966,000 | +12.2% | 5,274 | -2.6% | 0.01% | +25.0% |
| Q1 2019 | $861,000 | +274.3% | 5,413 | +125.2% | 0.00% | +300.0% |
| Q4 2018 | $230,000 | -38.5% | 2,404 | -9.2% | 0.00% | -50.0% |
| Q3 2018 | $374,000 | -63.5% | 2,648 | -59.6% | 0.00% | -66.7% |
| Q2 2018 | $1,025,000 | +128.8% | 6,551 | +135.6% | 0.01% | +100.0% |
| Q1 2018 | $448,000 | -7.6% | 2,780 | -5.5% | 0.00% | 0.0% |
| Q4 2017 | $485,000 | – | 2,942 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
| Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
| Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
| Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
| DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
| Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
| Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
| SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
| Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
| Diametric Capital, LP | 19,393 | $626,000 | 0.46% |